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1. Introduction 
Pyrazole is an effective inhibitor of catalase 
(EC 1.11.1.6) when given in vivo, but not in vitro 
[1,2]. It has been suggested [3] that the in vivo 
inhibition is mediated by ‘a product from the 
metabolism of pyrazole by the microsomal mixed- 
function oxidase system. . .in a process which can 
be prevented by alcohol.’ From a study of the 
action of pyrazole on tryptophan oxygenase 
(EC 1.13.1_12), another hemoprotein enzyme, it 
has also been proposed that the delayed in vivo 
inhibition seen after pyrazole treatment, much 
stronger than any comparable in vitro inhibition, 
results from either an inhibitory action on tryptophan 
oxygenase synthesis and/or a direct interference with 
the heme prosthetic group by an active derivative of 
pyrazole [4]. 
Work in our laboratory [S] has revealed that the 
major metabolite of pyrazole in rats is 4-hydroxy- 
pyrazole, excreted in hydrolyzable conjugated forms. 
Production of this metabolite is inhibited by ethanol. 
We now demonstrate that 4-hydroxypyrazole is a 
good inhibitor of catalase in vitro. 
2. Materials and methods 
3-Amino-1,2,Ctriazole was purchased from Nutri- 
tional Biochemicals (Cleveland, USA). 4-Hydroxy- 
pyrazole and 4-aminopyrazole were gifts from Lilly 
Research Laboratories (Indianapolis, USA). Pyrazole 
was purchased from Aldrich (Milwaukee, USA), and 
recrystallized from petroleum ether. Recrystallized 
North-Holland Publishing Company - Amsterdam 
beef liver catalase was purchased from Worthington 
(Freehold, NJ, USA). 
Catalase activity was determined by a slight 
modification of the Worthington [6] version of the 
assay of Beers [7]. The enzyme was diluted 1:lOOO 
with 0.05 M phosphate buffer, pH 7. At zero time, 
0.02 ml of this solution was mixed into a 3 ml 
(10 mm) quartz cuvette by the hanging-drop method 
of Orr [8]. When inhibitors were tested, they were 
added to the buffer and hydrogen peroxide in the 
cuvette a few minutes prior to the addition of the 
enzyme. The absorbance at 240 nm was then followed 
for 2 min using a Beckman DB-GT recording spectro- 
photometer. 
3. Results 
The effects of various concentrations of pyrazole, 
3-aminotriazole, 4_aminopyrazole, and 4.hydroxy- 
pyrazole are shown in table 1. Pyrazole has no effect 
on catalase in vitro, as previous papers [2,3,9] have 
pointed out. 4-Aminopyrazole is a good inhibitor 
of catalase in vitro, even with no pre-incubation with 
the enzyme. Feinstein et al. [lo] had shown that 
Qaminopyrazole is a potent inhibitor in vivo and in 
his pre-incubated system in vitro, with a concentration 
for 50% inhibition of 3.8 mM. As expected [ 111, 
3-aminotriazole is a weak catalase inhibitor in our 
un-incubated system, a concentration of 40.0 mM 
being required for 50% inhibition; whereas in 
Feinstein’s pre-incubated system, only 5.3 mM is 
necessary. Our result with 3-aminotriazole corresponds 
more closely with the result obtained by Heim [12] of 
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Table 1 
Percent inhibition of the catalatic reaction of catalase in vitro 
by various concentrations of inhibitors 
Concentration (mM) 1.0 1.5 2.0 3.0 4.0 5.0 
4-Aminopyrazole 40% 61% 73% - - - 
32% 61% 77% 
4-Hydroxypyrazole 8% - 32% 44% 56% 62% 
11% 32% 47% 54% 68% 
30.0 40.0 50.0 
3-Aminotriazole 34% 50% 63% 
37% 51% 60% 
Pyrazole - - 0% 
Rate with no inhibitor present was -0.0293 t 0.0006 (se) 
A/min, corresponding to about 2 units of enzyme/cuvette. 
Half inhibition concentration was obtained from a plot of 
percent inhibition versus log concentration of inhibitor. Each 
value represents one determination. 
‘slightly in excess of 0.05 M’ needed for half inhibition 
in vitro. 
4-Hydroxypyrazole is a much more potent inhibitor 
than 3-aminotriazole in our system, with 3.38 mM 
needed for half inhibition, a slightly weaker inhibition 
than that produced by 4-aminopyrazole. All three 
inhibitors are capable of producing 100% inhibition of 
catalase in vitro. Ethanol (54 mM) does not affect 
LChydroxypyrazole’s inhibition of catalase. 
4. Discussion 
These results, and our previous demonstration of the 
fact that ethanol almost completely inhibits metabolism 
of pyrazole to 4-hydroxypyrazole, indicate that 
Qhydroxypyrazole is the active metabolite of pyrazole 
inhibiting catalase in vivo. This direct demonstration 
obviates the need (1) to postulate an interference by 
ethanol with binding of 4-hydroxypyrazole to catalase 
[3], or (2) to invoke an inhibition of protein synthesis 
for the inhibition observed after administration of 
pyrazole in vivo [4,13] in the case of catalase. 
All of the most active compounds tested by 
Feinstein [lo] contained the N=CQ-N structure, 
were X = NH? or SH, except for 4-aminopyrazole. 
4Aminopyrazole, although very active as a catalase 
inhibitor, is the only compound listed in this category 
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by Feinstein which does not fit the rules for ‘irrever- 
sible catalase inhibitors’ laid down by Margoliash [l 11, 
with Feinstein’s revision that the primary amine group 
may be replaced by a thiol group. Hence it would not 
be surprising if 4-aminopyrazole, and its close analogue 
Qhydroxypyrazole, inhibited catalase via a different 
mechanism from that of 3-aminotriazole and its analogues. 
In fact, 4-aminopyrazole does differ from 3-amino- 
triazole in that the inhibition is as strong immediately 
after addition to catalase as it is after incubation with 
catalase and a source of peroxide [lo]. Inhibition by 
4-hydroxypyrazole also appears to take effect 
immediately. 
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